Bruce G. Hammond
Monsanto
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bruce G. Hammond.
Mycopathologia | 2005
Regina de la Campa; David C. Hooker; J. David Miller; A. W. Schaafsma; Bruce G. Hammond
Fumonisins are common contaminants of maize (Zea mays L.) grain products, especially in countries where maize is a major constituent of the diet and are harmful to human and animal health. There is a need to better define environmental conditions that favor fumonisin accumulation in the grain of maize. The impacts of biotic and abiotic factors, and hybrids containing the Cry1Ab protein from Bacillus thuringiensis (Bt), were associated with fumonisin accumulation in the grain of maize across contrasting environments in Argentina and the Philippines between 2000 and 2002. Average fumonisin concentrations in grain samples varied from 0.5 to 12 μg g−1 across field locations in Argentina, and from 0.3 to 1.8 μg g−1 across locations in the Philippines. The ratio of fumonisin B1 to fumonisin B2 was <3.0 in four of nine locations in Argentina, which proved to be due to a higher prevalence of Fusarium proliferatum in those locations. Most of the variability of total fumonisins among maize grain samples was explained by location or weather (47%), followed by insect damage severity in mature ears (17%), hybrid (14%), and with the use of Bt hybrids (11%). In Argentina, where conditions were more favorable for accumulation of fumonisin in the years considered, fumonisin concentrations were lower in Bt hybrids compared to their genetic isolines by an average of 40%. A model was developed to predict fumonisin concentration using insect damage to ears and weather variables as predictors in the model. Four periods of weather around silking were identified as critical for fumonisin concentrations at harvest. The model accounted for 82% of the variability of total fumonisin across all locations in 2 years of the study.
Critical Reviews in Toxicology | 2013
Bruce G. Hammond; John Kough; Corinne Herouet-Guicheney; Joseph M. Jez
Abstract This manuscript focuses on the toxicological evaluation of proteins introduced into GM crops to impart desired traits. In many cases, introduced proteins can be shown to have a history of safe use. Where modifications have been made to proteins, experience has shown that it is highly unlikely that modification of amino acid sequences can make a non-toxic protein toxic. Moreover, if the modified protein still retains its biological function, and this function is found in related proteins that have a history of safe use (HOSU) in food, and the exposure level is similar to functionally related proteins, then the modified protein could also be considered to be “as-safe-as” those that have a HOSU. Within nature, there can be considerable evolutionary changes in the amino acid sequence of proteins within the same family, yet these proteins share the same biological function. In general, food crops such as maize, soy, rice, canola etc. are subjected to a variety of processing conditions to generate different food products. Processing conditions such as cooking, modification of pH conditions, and mechanical shearing can often denature proteins in these crops resulting in a loss of functional activity. These same processing conditions can also markedly lower human dietary exposure to (functionally active) proteins. Safety testing of an introduced protein could be indicated if its biological function was not adequately characterized and/or it was shown to be structurally/functionally related to proteins that are known to be toxic to mammals.
Frontiers in Plant Science | 2015
Michael S. Koch; Jason M. Ward; Steven L. Levine; James A. Baum; John L. Vicini; Bruce G. Hammond
Bacillus thuringiensis (Bt) microbial pesticides have a 50-year history of safety in agriculture. Cry proteins are among the active insecticidal ingredients in these pesticides, and genes coding for Cry proteins have been introduced into agricultural crops using modern biotechnology. The Cry gene sequences are often modified to enable effective expression in planta and several Cry proteins have been modified to increase biological activity against the target pest(s). Additionally, the domains of different but structurally conserved Cry proteins can be combined to produce chimeric proteins with enhanced insecticidal properties. Environmental studies are performed and include invertebrates, mammals, and avian species. Mammalian studies used to support the food and feed safety assessment are also used to support the wild mammal assessment. In addition to the NTO assessment, the environmental assessment includes a comparative assessment between the Bt crop and the appropriate conventional control that is genetically similar but lacks the introduced trait to address unintended effects. Specific phenotypic, agronomic, and ecological characteristics are measured in the Bt crop and the conventional control to evaluate whether the introduction of the insect resistance has resulted in any changes that might cause ecological harm in terms of altered weed characteristics, susceptibility to pests, or adverse environmental impact. Additionally, environmental interaction data are collected in field experiments for Bt crop to evaluate potential adverse effects. Further to the agronomic and phenotypic evaluation, potential movement of transgenes from a genetically modified crop plants into wild relatives is assessed for a new pest resistance gene in a new crop. This review summarizes the evidence for safety of crops containing Cry proteins for humans, livestock, and other non-target organisms.
Regulatory Toxicology and Pharmacology | 2008
Bruce G. Hammond; Joan K. Lemen; Gulam Ahmed; Kathleen D. Miller; Jeannie Kirkpatrick; Tammye Fleeman
Long chain polyunsaturated fatty acids (LC-PUFAs) in the diet reduce risk of cardiac mortality. Fish oils are a dietary source of LC-PUFAs (EPA, DHA) but intake is low in Western diets. Adding beneficial amounts of LC-PUFAs to foods is limited by their instability and potential to impart off-flavors. Stearidonic acid (SDA), a precursor of EPA in man, is more stable than EPA/DHA in food matrices. SDA is present in fish oils (0.5-4%) and in nutraceuticals (echium, borage oil). Genes for Delta6, Delta15 desaturases were introduced into soybeans that convert linoleic and alpha-linolenic acid to SDA (15-30% fatty acids). Since addition of SDA soybean oil into human foods increases SDA intake, toxicology studies were undertaken to assess its safety. In a 28-day pilot study, rats were gavaged with SDA soybean oil at dosages up to 3g/kg body weight/day; no treatment-related adverse effects were observed. A 90-day/one generation rat reproduction study was subsequently conducted where SDA soybean oil was added to diets to provide daily doses of 1.5 and 4 g/kg body weight. There were no treatment-related adverse effects on parental animals or on reproductive performance and progeny development.
Regulatory Toxicology and Pharmacology | 2002
Bruce G. Hammond; Dale A. Mayhew; Larry D. Kier; Richard W. Mast; Wayne J. Sander
The purpose of this study was to determine the potential toxicity of docosahexaenoic acid-rich microalgae from Schizochytrium sp. (DRM), administered in the diet to rats for at least 13 weeks. DRM was administered in the diet to groups of 20 male and 20 female Sprague-Dawley derived rats (Crl:CD(SD)BR) to provide dosages of 0, 400, 1500, and 4000 mg/kg/day for at least 13 weeks. DRM contained high levels of fat (approximately 41% w/w) of which long-chain highly unsaturated fatty acids (PUFAs) were a major component. Vitamin E acetate was added to DRM at manufacture to provide supplementary dietary antioxidant given the highly unsaturated fat content of DRM. Untreated controls received the basal diet only. An additional group of 20 males and 20 females received basal diet mixed with fish oil (Arista) to provide a target dosage of 1628 mg/kg/day, an amount of fat comparable to that received by rats administered the highest dose of DRM. Vitamin E acetate was also added to the fish oil to provide a comparable level of dietary antioxidant provided to high-dose DRM rats. There were no treatment-related effects in clinical observations, body weights or weight gains, food consumption, hematologic or urinalysis values, gross necropsy findings, or organ weights and there were no deaths. The only treatment-related changes in clinical chemistry parameters were decreases in high-density lipoproteins and cholesterol in the DRM and fish oil groups when compared to the untreated controls. These changes were expected based on the high PUFA content of DRM and fish oil. There were no microscopic findings suggestive of toxicity. Periportal hepatocellular fat vacuolation (accumulation of fat) was observed only in the livers of female rats in both the DRM (all dosages) and fish oil groups. This finding was expected given the higher fat content of both the DRM and the fish oil diets compared to the basal diet fed to the untreated controls. A slight increase in the incidence, but not severity, of cardiomyopathy was observed only in the 4000 mg/kg/day DRM males. This finding was not considered adverse because cardiomyopathy occurs spontaneously in rats and especially male rats of the Sprague-Dawley strain when fed high levels of fat. Since cardiomyopathy does not develop in other species including primates fed high-fat diets, its occurrence in rats is considered to have little relevance to human health. This study demonstrates that administration of DRM did not produce any treatment-related adverse effects in Sprague-Dawley rats of relevance to humans at dosages up to 4000 mg/kg/day for 13 weeks.
Toxicology and Industrial Health | 1987
Bruce G. Hammond; George J. Levinskas; Ellen C. Robinson; Frederick R. Johannsen
This review compares the subchronic toxicity of butyl benzyl phthalate (BBP) across several species. Data from the published literature as well as previously unpublished studies sponsored by Monsanto are presented. BBP-induced toxicity occurs only at relatively high levels of exposure and is dependent on the species, age and strain of test animals used. These factors should be considered in extrapolating findings from animal toxicology studies to humans when assessing the safety of BBP.
Archive | 2012
Bruce G. Hammond; Michael S. Koch
There is a 50-year history of safe use and consumption of agricultural food crops sprayed with commercial Bt (Bacillus thuringiensis) microbial pesticides and a 14 year history of safe consumption of food and feed derived from Bt crops. This review summarizes the published literature addressing the safety of Cry insect control proteins found in both Bt microbial pesticides and those introduced into Bt agricultural crops. A discussion on the species-specific mode of action of Cry proteins to control target insect pests is presented. This information provides the scientific basis for the absence of toxicity of Cry proteins towards non-target organisms that has been confirmed in numerous mammalian toxicology studies. A human dietary exposure assessment for Cry proteins has also been provided which includes information that food processing of Bt crops such as maize leads to loss of functionally active Cry proteins in processed food products. Lastly the food and feed safety benefits of Bt crops are briefly summarized including lower insecticide use and reduction in fumonisin mycotoxin contamination of grain.
Toxicological Sciences | 1986
Ellen C. Robinson; Bruce G. Hammond; Frederick R. Johannsen; George J. Levinskas; Dean E. Rodwell
Santicizer 141 plasticizer (2-ethylhexyldiphenyl phosphate) and Santicizer 148 plasticizer (isodecyldiphenyl phosphate) were tested for teratogenic activity in Charles River COBS CD rats. Groups of 25 mated females were given 0, 300, 1000, or 3000 mg/kg/day by gavage on Days 6 through 15 (Santicizer 141) or 6 through 19 (Santicizer 148) of gestation. Mean maternal body weight gains were slightly and severely reduced at the mid- and high-dose levels of Santicizer 141, respectively. Body weights were not affected by treatment with Santicizer 148. Most malformations found in groups treated with either plasticizer occurred as single incidences and have been observed in historical controls. Thus, no teratogenic response was observed in rats after treatment with either of these two alkylaryl phosphates during the period of organogenesis.
Critical Reviews in Food Science and Nutrition | 2016
Michael S. Koch; John M. DeSesso; Amy Lavin Williams; Suzanne M. Michalek; Bruce G. Hammond
To determine the reliability of food safety studies carried out in rodents with genetically modified (GM) crops, a Food Safety Study Reliability Tool (FSSRTool) was adapted from the European Centre for the Validation of Alternative Methods’ (ECVAM) ToxRTool. Reliability was defined as the inherent quality of the study with regard to use of standardized testing methodology, full documentation of experimental procedures and results, and the plausibility of the findings. Codex guidelines for GM crop safety evaluations indicate toxicology studies are not needed when comparability of the GM crop to its conventional counterpart has been demonstrated. This guidance notwithstanding, animal feeding studies have routinely been conducted with GM crops, but their conclusions on safety are not always consistent. To accurately evaluate potential risks from GM crops, risk assessors need clearly interpretable results from reliable studies. The development of the FSSRTool, which provides the user with a means of assessing the reliability of a toxicology study to inform risk assessment, is discussed. Its application to the body of literature on GM crop food safety studies demonstrates that reliable studies report no toxicologically relevant differences between rodents fed GM crops or their non-GM comparators.
Toxicological Sciences | 1985
Bruce G. Hammond; Steven J. Barbee; Allan G. Wheeler; Tito Cascieri
The mutagenic potential of monosodium cyanurate was evaluated using in vitro and in vivo tests. All in vitro tests were carried out in the presence and absence of metabolic activation. In each assay, the highest concentration tested generally exceeded the solubility of monosodium cyanurate in the incubation medium. In the Salmonella microbial assay, monosodium cyanurate was not mutagenic towards test strains TA 98, 100, 1535, and 1537 up to a concentration of 10,000 micrograms/plate. Monosodium cyanurate did not induce forward mutations at the TK locus of L5178Y mouse lymphoma cells up to a concentration of 2000 micrograms/ml. No significant increases in sister chromatid exchanges were observed when monosodium cyanurate was incubated with Chinese hamster ovary cells at concentrations up to 1500 micrograms/ml. In an in vivo test, rats were administered monosodium cyanurate by gavage at single dosages up to 5000 mg/kg and killed 24 and 48 hr after dosing. Bone marrow cells were collected and examined for chromosomal aberrations. At the time points examined, there was no evidence of monosodium cyanurate-induced chromosomal aberrations in rat bone marrow cells.